Akili Interactive

By Dave Muoio April 11, 2019
This morning, digital therapeutics maker Akili Interactive announced it has added a new CFO and general counsel to its ranks. The former is Santosh Shanbhag, a senior executive who boasts a prior VP role at Vertex Pharmaceutical as well as positions at Capgemini Consulting and Texas Instruments. Jacqueline Studer, on the other hand, served as CVP, general counsel and secretary at IDEXX...

Left to right: Dr. Daniel Kraft, Fitbit's Any McDonough, Verily's Dr. Jess Mega and Akili's Eddie Martucci chat on stage at CES 2019’s Digital Health Summit

By Dave Muoio January 9, 2019
Digital therapeutics are a nascent corner of the healthcare technology industry. With few precedents available outside of novel drugs or medical devices, it would make sense that Pear Therapeutics, Proteus and other digital therapeutics companies furthest along the regulatory pipeline align themselves with industry partners well versed in selling and supporting a medical product. As such, it came...
By Dave Muoio January 3, 2019
A small feasibility study conducted by the Children’s Hospital of Philadelphia suggests that Project: Evo, the digital medicine developed by Akili Interactive Labs that is delivered via a video game, continually engaged children with autism spectrum disorder (ASD) and reduced their ADHD symptoms, although more objective measures of cognitive control were mixed. Topline data Nineteen children aged...
By Dave Muoio November 26, 2018
Yadin Shemmer has been named the new CEO of Mango Health, the maker of a digital medication management platform. Shemmer, who was previously the company’s president, will take over the job from founder Jason Oberfest, who will continue to serve as a special advisor to the company. “I am thrilled to have Yadin take the helm at Mango Health to spearhead the continued growth of the company,”...
By Dave Muoio August 9, 2018
Boston-based digital therapeutics company Akili Interactive Labs announced this morning that it has added an extra $13 million to its previously announced Series C financing. Together, this brings the company’s 2018 funding to $68 million, and its total backing to just over $140 million. The additional investment from CLSA, Omidyar Technology Ventures, Digital Garage Group, and Fearless Ventures...
By Dave Muoio May 9, 2018
This morning, Boston-based Akili Interactive Labs announced the closure of a $55 million Series C funding round. The investment was led by Temasek, with participation from Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Fund, and Brooklands Capital Strategies. According to the company, this new funding will be used to support development, regulatory...
By Laura Lovett April 10, 2018
This week has spurred some major patent announcements from digital health companies Akili Interactive and Sonde Health, which are both affiliated with PureTech Health, a cross disciplinary biopharma company. The two companies announced they have been granted the rights to multiple international digital health patents. Akili revealed they are developing a technology aimed at using neural...
By Jonah Comstock October 25, 2017
A group of  health startups in the burgeoning digital therapeutics space have joined together to create a new industry association, the Digital Therapeutics Alliance (DTA). “Digital therapeutics are re-writing our definition of medicine,” Akili Interactive CEO Eddie Martucci said in a statement. “It’s critical that industry, academia, government, and the medical community work together in the...
By Heather Mack March 17, 2017
The human brain and the seemingly infinite number of health complications that can befall it are complex. As such, there aren’t universally agreed-upon therapies and treatments for conditions ranging from depression and chronic pain to stroke and Parkinson’s disease. But recent, rapid advances in neuroscience research and digital technology are enabling a new wave of tools to gain traction in...
swiss-apo.com/rezeptfrei/levitra-kaufen

details by link swiss-apo.net

rtic 30